Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Blood Group Typing Market Poised To Hit $6.46 Billion By 2030 With A 13.2% CAGR
The blood group typing market has experienced substantial growth in recent years. It is projected to increase from $3.46 billion in 2025 to $3.93 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.9%. This historic growth is attributable to the expansion of blood transfusion procedures, the growth in hospital laboratory services, rising surgical volumes, increased blood donation screening, and the standardization of transfusion protocols.
The blood group typing market size is projected to experience rapid expansion in the coming years. It is expected to reach $6.46 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 13.2%. This anticipated growth during the forecast period is due to factors such as the increasing adoption of molecular typing techniques, a rising demand for rapid compatibility testing, the expansion of automated laboratory workflows, growing investments in transfusion safety systems, and technological advances in blood group diagnostics. Key trends during this period include the increasing adoption of automated blood typing systems, a rising demand for high-throughput testing platforms, the growing use of molecular blood group typing, the expansion of advanced reagent and kit solutions, and an enhanced focus on transfusion safety.
Get A Free Sample Report With In-Depth Market Insights:
Blood Group Typing Market Growth Backed By Core Demand Fundamentals
The rising volume of blood donations and transfusions served as a primary impetus for the blood group typing market during the historic period. Various nonprofit organizations, government organizations, and other agencies are actively emphasizing the crucial importance of blood donations and transfusions, and are spreading awareness through numerous campaigns. A surge in blood donations consequently heightened the demand for blood group typing, allowing donors to identify their specific blood type. For instance, in February 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that, in 2024, there are approximately 7 million blood donors and more than 14 million units of blood transfused annually in the United States. This increased incidence of blood donations and transfusions thereby substantially contributed to the expansion of the blood typing market.
Blood Group Typing Market Segment Landscape And Growth Outlook
The blood group typing market covered in this report is segmented –
1) By Test Type: Antibody Screening, Cross-Matching Tests, ABO Tests, Antigen Typing, HLA Typing
2) By Product: Instruments, Reagents And Kits
3) By Techniques: Serology Tests, Molecular Tests
4) By End User: Hospital Based Laboratories, Independent Laboratories And Blood Banks
Subsegments:
1) By Antibody Screening: Indirect Coombs Test, Enzyme-Linked Immunosorbent Assay (ELISA)
2) By Cross-Matching Tests: Major Crossmatch, Minor Crossmatch, Electronic Crossmatch
3) By ABO Tests: Forward Typing, Reverse Typing
4) By Antigen Typing: Rh Factor Typing, Kell Typing, Other Blood Group Antigen Typings
5) By HLA Typing: Serological Methods, Molecular Methods (PCR-based)
Blood Group Typing Market Growth Trends Reshaping The Competitive Landscape
Companies operating in the blood group typing market are developing innovative products with advanced technologies, such as next-generation sequencing (NGS), to enhance the accuracy and efficiency of blood typing processes. NGS facilitates the detailed analysis of genetic variations in blood group antigens, providing more precise and comprehensive blood group typing. For instance, in April 2023, Metropolis Healthcare Limited, an India-based health company, launched the NextGen HLA Typing Test, which utilizes next-generation sequencing (NGS) technology to enhance the accuracy of human leukocyte antigen (HLA) typing for organ transplantation. This advanced testing method is designed to improve compatibility assessments between donors and recipients, which is crucial for successful transplants.
Blood Group Typing Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the blood group typing market are Grifols S.A., Bio-Rad Laboratories Inc., Immucor Inc., Ortho-Clinical Diagnostics Inc., Quotient Limited, AXO Science SAS, Agena Bioscience Inc., Merck KGaA, Beckman Coulter Inc., DIAGAST SAS, Thermo Fisher Scientific Inc., One Lambda Inc., Tulip Diagnostics (P) Ltd., Guangzhou Wondfo Biotech Co. Ltd., DiaSorin S.p.A., Grifols Diagnostic Solutions Inc., Hemo bioscience Inc., Medion Diagnostics GmbH, ZenTech S.A., BioMedomics Inc., Lifespan Diagnostics LLC
View The Full Blood Group Typing Market Report:
Blood Group Typing Market Geographic Spread And Regional Opportunities
North America was the largest region in the blood group typing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the blood group typing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
